Skip to the content

TruGraf® Rules Out Silent Kidney Rejection.

A Game-Changing Alternative to Surveillance Biopsies

Now covered by Medicare, TruGraf® is the first biomarker-guided blood monitoring assay to rule out subclinical rejection for patients with stable renal function.

Connect with us